TerminatedISRCTN25691213
Atomoxetine for attention deficit hyperactivity disorder (ADHD) in children with special educational needs
Research studyAges 7–15United Kingdom
Understand this study
Who could participate?
Listed age limits: 7 years to 15 years.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- King's College London (UK)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 7 Years to 15 Years
- Official registry ID
- ISRCTN25691213
- Official title
Show the full official title
Atomoxetine for attention deficit hyperactivity disorder (ADHD) in children with special educational needs
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is King's College London (UK), a university.
Who can participate?
Listed age limits: 7 years to 15 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
A clinical trial to investigate how effective a stimulant medication is compared to a non-stimulant medication in patients who have been diagnosed with attention deficit hyperactivity disorder (ADHD) and also have a history of either psychosis or Bipolarity
Sleep Buddy plus usual care for sleep problems in children with ADHD
